title: Profiling the immune stromal interface in breast cancer and its potential for clinical impact.
abstract: Advances in DNA sequencing technologies, as well as refined bioinformatics methods for interpretation of complex datasets, have provided the opportunity to comprehensively assess gene expression in tumours and their surrounding microenvironment. More recently, these advances have highlighted the interplay between the immune effector mechanisms and breast cancer cell biology, emphasizing the long-recognized link between immunity and cancer. Studying immune-associated genes has not only resulted in further stratification within the broad pathological types of breast cancers, but also provided further biological insights into the complex heterogeneity within breast cancer subgroups. On the basis that anti-cancer therapies can modify the host-tumour interaction, investigators have focused their attention on the predictive value of immune parameters as markers of therapeutic anti-tumour response. We discuss the current status of immune signatures in breast cancer and some of the fundamental limitations that need to be overcome to move these discoveries into clinic.
authors.affiliation: Breakthrough Breast Cancer Research Unit, Guy's Hospital, Kings College London; Kings Health Partners AHSC, London, UK.
authors.forename: Sheeba
authors.initials: S
authors.lastname: Irshad
authors.forename: Anita
authors.initials: A
authors.lastname: Grigoriadis
authors.forename: Katherine
authors.initials: K
authors.lastname: Lawler
authors.forename: Tony
authors.initials: T
authors.lastname: Ng
authors.forename: Andrew
authors.initials: A
authors.lastname: Tutt
keywords: Breast cancer; Genomic biomarkers; Immune stromal interface
references.citation: Nature. 2007 Dec 6;450(7171):903-7
references.pmid: 18026089
references.citation: J Exp Med. 2011 Mar 14;208(3):491-503
references.pmid: 21383056
references.citation: PLoS Genet. 2008 Apr 25;4(4):e1000054
references.pmid: 18437204
references.citation: Breast Cancer Res. 2011 Oct 06;13(5):R97
references.pmid: 21978456
references.citation: Sci Transl Med. 2011 Nov 9;3(108):108ps44
references.pmid: 22072636
references.citation: Genes Immun. 2009 Jun;10(4):285-96
references.pmid: 19404300
references.citation: Mol Oncol. 2010 Jun;4(3):255-66
references.pmid: 20434415
references.citation: Cancer Res. 2008 Jul 1;68(13):5405-13
references.pmid: 18593943
references.citation: Int J Gynecol Cancer. 2000 Nov;10(6):477-487
references.pmid: 11240718
references.citation: Breast Cancer Res Treat. 2010 Apr;120(3):655-61
references.pmid: 20204499
references.citation: Nature. 2009 Dec 24;462(7276):1005-10
references.pmid: 20033038
references.citation: J Natl Cancer Inst. 2006 Feb 15;98(4):262-72
references.pmid: 16478745
references.citation: Gynecol Oncol. 2008 May;109(2):215-9
references.pmid: 18314181
references.citation: Cancer Res. 2007 Nov 15;67(22):10669-76
references.pmid: 18006808
references.citation: Nat Immunol. 2002 Nov;3(11):991-8
references.pmid: 12407406
references.citation: Nature. 2002 Jan 31;415(6871):530-6
references.pmid: 11823860
references.citation: J Natl Cancer Inst. 2011 Aug 17;103(16):1252-63
references.pmid: 21791674
references.citation: Cancer Res. 2007 Apr 15;67(8):3845-52
references.pmid: 17440099
references.citation: J Clin Oncol. 2010 Jan 1;28(1):105-13
references.pmid: 19917869
references.citation: Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8715-21
references.pmid: 16361558
references.citation: N Engl J Med. 2012 Mar 8;366(10):883-892
references.pmid: 22397650
references.citation: Nat Med. 2009 Oct;15(10):1170-8
references.pmid: 19767732
references.citation: Breast. 2011 Dec;20(6):568-73
references.pmid: 21843944
references.citation: Science. 2010 Feb 26;327(5969):1098-102
references.pmid: 20185720
references.citation: Nat Med. 2008 May;14(5):518-27
references.pmid: 18438415
references.citation: Nature. 2000 Aug 17;406(6797):747-52
references.pmid: 10963602
references.citation: PLoS One. 2009 Oct 22;4(10):e7556
references.pmid: 19847310
references.citation: Breast Cancer Res. 2010;12(5):R68
references.pmid: 20813035
references.citation: Breast Cancer Res. 2009;11(2):R15
references.pmid: 19272155
references.citation: J Clin Oncol. 2012 Jun 1;30(16):1996-2004
references.pmid: 22508827
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):9212-7
references.pmid: 10430922
references.citation: PLoS One. 2011 Feb 10;6(2):e17014
references.pmid: 21347333
references.citation: Mod Pathol. 2012 May;25(5):740-50
references.pmid: 22282309
references.citation: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14295-300
references.pmid: 11121035
references.citation: Nature. 2007 Oct 4;449(7162):557-63
references.pmid: 17914389
references.citation: J Clin Oncol. 2010 Oct 1;28(28):4316-23
references.pmid: 20805453
references.citation: Lancet. 2005 Feb 19-25;365(9460):671-9
references.pmid: 15721472
references.citation: Mutat Res. 2010 Nov 10;693(1-2):3-18
references.pmid: 20691711
references.citation: Nature. 2008 Jul 24;454(7203):436-44
references.pmid: 18650914
references.citation: Nat Med. 2007 Sep;13(9):1050-9
references.pmid: 17704786
references.citation: Cancer. 2009 Jul 1;115(13):2891-902
references.pmid: 19472394
references.citation: Clin Chem. 2007 Jun;53(6):1084-91
references.pmid: 17463177
references.citation: Breast Cancer Res. 2011;13(6):R126
references.pmid: 22151962
references.citation: Science. 2010 Nov 5;330(6005):827-30
references.pmid: 21051638
references.citation: Breast Cancer Res Treat. 2011 Apr;126(2):407-20
references.pmid: 20490655
references.citation: Science. 2001 Feb 16;291(5507):1304-51
references.pmid: 11181995
references.citation: Nature. 2012 Apr 04;486(7403):395-9
references.pmid: 22495314
references.citation: Genome Biol. 2007;8(8):R157
references.pmid: 17683518
references.citation: Nature. 2001 Feb 15;409(6822):860-921
references.pmid: 11237011
references.citation: Carcinogenesis. 2012 Jun;33(6):1126-33
references.pmid: 22491715
references.citation: J Clin Oncol. 2012 Feb 20;30(6):647-60
references.pmid: 22271477
references.citation: J Leukoc Biol. 2008 Oct;84(4):988-93
references.pmid: 18515327
references.citation: Lancet. 2003 May 10;361(9369):1590-6
references.pmid: 12747878
references.citation: N Engl J Med. 2009 Feb 19;360(8):790-800
references.pmid: 19228622
references.citation: Breast Cancer Res. 2010;12(5):R85
references.pmid: 20946665
references.citation: Mol Cancer. 2011 Jul 21;10:86
references.pmid: 21777462
references.citation: Lancet Oncol. 2010 Apr;11(4):339-49
references.pmid: 20181526
references.citation: BMC Genomics. 2006 Apr 27;7:96
references.pmid: 16643655
references.citation: Nature. 2012 Apr 18;486(7403):346-52
references.pmid: 22522925
references.citation: Nat Med. 2010 May;16(5):586-91, 1p following 591
references.pmid: 20400961
references.citation: Breast Cancer Res. 2006;8(6):216
references.pmid: 17164010
references.citation: Breast Cancer Res Treat. 2012 Feb;131(3):871-80
references.pmid: 21479927